The Future is Now: The 17th Annual Specialty Summit by Magellan Rx Management September 11, 2020Biosimilars, COVID-19, Future of Genomics, Future of Specialty Pharmacy, Magellan, Magellan Health, Magellan RX, Magellan Rx Management, Magellan Rx Management Specialty Summit, MRx Specialty Summit, Oncology Biosimilars, Precision Medicine in Oncology, specialty drugs
Top 10 Takeaways: 2019 Medical Pharmacy Trend Report by Kristen Reimers April 21, 2020Billion Dollar Drugs, Biosimilars, Magellan, Magellan Health, Magellan RX, Magellan Rx Management, Medical Pharmacy, Medical Pharmacy Management, Medical Pharmacy Trend Report, Oncology Biosimilars, Specialty Clinical Solutions, Specialty Medications
3 Key Trends to Consider for Oncology Management by Rebecca Borgert June 5, 2019Cancer, Cancer treatment, FDA, Magellan, Magellan Health, Magellan Healthcare, Magellan RX, Magellan Rx Management, Medical Benefit Drug Management, Medical Oncology Spend, Novel Cancer Drugs, Oncology, Oncology Biosimilars, Oncology Management
